Free Trial

Best Cannabis Stocks To Consider - September 17th

Tilray Brands logo with Medical background

Key Points

  • Tilray Brands, Indivior, and Canopy Growth emerge as the top cannabis stocks to watch, driven by recent high trading volumes and significant market presence in both medical and recreational marijuana sectors.
  • Tilray Brands is expanding its operations internationally, offering cannabis products in various countries, including Argentina, Germany, and South Africa.
  • Indivior focuses on developing treatments for opioid dependence and related disorders, indicating a significant role in mental health and addiction services alongside its cannabis-related activities.
  • Five stocks to consider instead of Tilray Brands.

Tilray Brands, Indivior, and Canopy Growth are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are publicly traded shares of companies involved in the cultivation, production, distribution or ancillary services of the legal cannabis industry. Investing in these stocks gives individuals exposure to both medical and recreational marijuana markets as well as related businesses like biotech, retail and equipment suppliers. Their performance is often influenced by regulatory changes, market sentiment and evolving consumer trends. These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Tilray Brands (TLRY)

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

Read Our Latest Research Report on TLRY

Indivior (INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Read Our Latest Research Report on INDV

Canopy Growth (CGC)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Read Our Latest Research Report on CGC

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tilray Brands Right Now?

Before you consider Tilray Brands, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.

While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.